Norway· NO-ID_6DBF7718-EB16-492D-BC30-C32CE149B034
Lomustine medac
A lomustine product containing lomustine, registered in Norway by Medac. The same ATC class is registered in 10 of our 19 countries.
Checked against FEST (Norway) on
Informational only — not a medical device.
Where it is registered
Lomustine is registered in 10 of 19 countries.
Countries holding a registration under ATC L01AD02 (lomustine), each read from that country’s own register.
- This record: Norway, from FEST (Norway)
- 4 of them publish a price we can compare per daily dose
Lomustine · ATC L01AD02
10 / 19 countries
- Canada
- Denmark
- Finlandprice
- Franceprice
- Germany
- Netherlands
- Norwayprice
- Sweden
- United Kingdom
- United Statesprice
The record
At a glance
FEST (Norway)- Active substance
- Lomustine
- Manufacturer
- Medac
- Country
- Norway (NO)
- ATC code
- L01AD02
- ATC class
- Lomustine
- Reimbursed
- Not published by this register
- Source register
- FEST (Norway)
- Last checked
- September 25, 2026
Packs & prices · 3
- gtin7046261368872
- no_merkevare_idID_6DBF7718-EB16-492D-BC30-C32CE149B034
- no_varenummer29054620
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
166 interactions on record for lomustine.
Graded by severity as the source publishes them — 36 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Lomustine · interactions on record
166 records
- 36 severe
- 112 moderate
- 18 minor
Most severe, free to view
- CimetidineA02BA01severe
- MipomersenC10AX11severe
- LomitapideC10AX12severe
- Nalidixic acidJ01MB02severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Lomustine in 9 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomLomustine 40mg capsulesCST Pharma Ltd
- NetherlandsLomustine BModesto capsules, hard 40 mgBModesto B.V.
- FinlandLomustine medacMedac Gesellschaft Für Klinische Spezialpräparate mbH
- FranceLOMUSTINE MEDAC 40 mg, géluleMEDAC GESELLSCHAFT FUR KLINISCHE SPEZIALPRAPARATE (ALLEMAGNE)
- CanadaCEENUBRISTOL-MYERS SQUIBB CANADA
- SwedenLomustine Medac 40 mg Kapsel, hårdmedac Gesellschaft für klinische Spezialpräparate mbH
- United StatesLOMUSTINECarnegie Pharmaceuticals LLC
- SpainBELUSTINE CAPSULASBellon
Authorised across Europe · EMA
The same active substance is authorised in 7 EEA countries. Names it is sold under:
- Austria · Lomustin (Ccnu) Medac
- Germany · Cecenu®
- Denmark · Lomustine Medac
- Finland · Lomustine Medac
- France · Lomustine Medac
- United Kingdom (Northern Ireland) · Lomustine Medac
- Sweden · Lomustine
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/1e679cf5-5d71-4910-8a3b-8ee006975220 GET /v1/drugs/1e679cf5-5d71-4910-8a3b-8ee006975220?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Kapsel, hard",
"source": "fest",
"status": "A",
"atc_name": "Lomustin",
"merkevare_id": "ID_6DBF7718-EB16-492D-BC30-C32CE149B034",
"name_form_strength": "Lomustine medac kaps 40 mg",
"prescription_group": "C"
}See everything about lomustine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.